National

ICMR approves use of diagnostic machine used for drug-resistant TB for COVID-19

Brihanmumbai Municipal Corporation doctors and medical staff take samples of Mumbai police and their families for COVID-19 testing at Mumbai Police Officer Quarters, in Borivali, Mumbai./ File photo

Brihanmumbai Municipal Corporation doctors and medical staff take samples of Mumbai police and their families for COVID-19 testing at Mumbai Police Officer Quarters, in Borivali, Mumbai./ File photo   | Photo Credit: Aadesh Choudhari

As part of its efforts to ramp up the testing capacity, the Indian Council of Medical Research (ICMR) has approved the use of diagnostic machines used for testing drug-resistant tuberculosis for conducting coronavirus tests.

The ICMR has validated ‘TruenatTM beta CoV test on TruelabTM workstation’ and has recommended it as a screening test, the apex health research body said on Friday.

Issuing a guidance on the use of Truenat beta CoV, the ICMR said throat/nasal swabs will be collected in the viral transport medium (VTM) with virus lysis buffer provided along with the kit.

ICMR study points to community transmission

“Earlier studies have shown that virus lysis buffer neutralizes Nipah and H1N1 viruses. The results of stability of viral RNA after neutralization of SARS-CoV-2 by virus lysis buffer are awaited from ICMR-NIV, Pune.”

“Till such time, Truenat beta CoV test should only be performed with all biosafety precautions in BSL-2 or BSL-3 setups at laboratories,” it said.

The revised guidelines will be issued once the results from ICMR-NIV, Pune are available, it said.

The death toll due to the novel coronavirus rose to 199 and the number of cases climbed to 6,412 in the country on Friday, according to the Union Health Ministry.

However, a PTI tally of figures reported by various states as on Thursday showed at least 6640 cases and 227 deaths.

There has been a lag in the Union Health Ministry figures, compared to the number of cases announced by different states, which officials attribute to procedural delays in assigning the cases to individual states.

A letter from the Editor


Dear reader,

We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.

Support Quality Journalism
Related Topics
Recommended for you
This article is closed for comments.
Please Email the Editor

Printable version | Jun 5, 2020 7:01:00 AM | https://www.thehindu.com/news/national/icmr-approves-use-of-diagnostic-machine-used-for-drug-resistant-tb-for-covid-19/article31308299.ece

Next Story